However, in breast cancer, aromatase levels are increased by the activation of the II and I.3 promoters in malignant epithelial cells and adjacent fibroblasts, and by the I.7 promoter in adjacent endothelial cells [46,47]. Here, CYP19A1 is linked to breast cancer.